Annual Digital Conference Programme October 1st - October 2nd … · Oral and poster abstracts 31...

bsaci The British Society for Allergy and Clinical Immunology

www.bsacimeeting.org

Annual Digital Conference Programme

October 1st - October 2nd 2020


ALK_Allergy_A5_Advert_Final_outlined.indd 1ALK_Allergy_A5_Advert_Final_outlined.indd 1 17/09/2020 17:5417/09/2020 17:54

https://allergy-thinkingdifferently.com

3bsacimeeting.org

Contents

4 Welcome letter

6 BSACI 2020 Committee

7 Conference information

11 Programme Day 1: Thursday 1st October 2020

14 Programme Day 2: Friday 2nd October 2020

19 Industry sponsored satellite symposia

22 Oral and poster abstracts

31 Sponsors and exhibitors


4 BSACI Programme 2020

Dear Friends and Colleagues,

Welcome to the 2020 British Society for Allergy and Clinical Immunology Conference! This year we bring you a conference with a difference for a year that has been very different! We very much hope that you will enjoy the Annual Meeting through our online platform which has been purpose-build to facilitate interaction and discussion.

This year we’ll be highlighting allergy and airway management across the life course in our President’s plenary with speakers Professor Mika Makela from Finland, Dr Anna Murphy from Leicester and Professor Stephen Durham from London. Additionally, we shall be discussing some key topical issues of importance for the Society. Mr Jon Cruddas MP will speak about ‘Meeting the Challenge of the National Allergy Crisis’ and on Friday, we have a full session dedicated to ‘Overcoming Inequalities’ with some inspiring speakers, discussing how to bring about change. We’ve also teamed up with ITN to produce a video exploring report on anaphylaxis with a focus on the ‘Spare pens in schools’ initiative.

We focus on respiratory allergy with a plenary on optimising respiratory capacity for patients and another, discussing the impact of environmental allergens in asthma control. We have also dedicated a session to discussing ethics in allergy. Additionally, we have kept our panel questions after each speaker, re-designed our practical workshops to fit an online platform and joined with The British Society of Cutaneous allergy to prepare an exciting set of lectures on patch testing in atopics and oromucosal reactions.

Dr Glenis Scadding will be delivering this year’s Jack Pepys Lecture and Dr Michael Perkin will present The Harry Morrow Brown Lecture in our Celebrating Excellence session. We’ve had an array of amazing abstracts submitted this year and we’ll again be awarding our prestigious Barry Kay awards in each of our abstract categories. Do join us, to celebrate our abstract winners and the William Frankland Award recipient, at our Celebrating Excellence session at 16:00 on Thursday 1st October.

Our thanks to the BSACI Programme Planning Committee: Fiona Rayner (BSACI Chief Executive), Dr Tammy Rothenberg, Rachel Griffin, Lucy Common, Matt Doyle, Natasha Gunawardana, Hannah Kramer, Catherine Hyland (Clinical and Experimental Allergy Representative) and our dedicated conferencing partners at Medivents, Karen Anthony and Lucie Flint, who have gone above and beyond this year to transition our conference to a condensed online programme in a very short time frame.

Annual Digital ConferenceOctober 1st - October 2nd 2020

5bsacimeeting.org

Dr Tom MarrsScientific Programme Lead

Professor Adam FoxPresident

Dr Nandinee PatelDeputy Scientific Programme Lead

Additionally, BSACI would like to thank Thermo Fisher Scientific for supporting our PR campaign on social media in the run up to the meeting. We would also like to thank Pauline Kent and Jerry Budden from Satellite PR who have be working with BSACI in developing and running our social media and PR Campaign.

We would also very much like to thank our sponsors and exhibitors for their continued support, in a changing conference landscape. Their contributions have been essential to ensuring that we have been able to deliver the conference in this new format this year. Please do visit the ‘stands’ in the exhibition area, which our team have done a great job of replicating for the online platform.

We hope you find this year’s meeting a rewarding experience, filled with ample opportunities to connect with colleagues and speakers alike.

The British Society for Allergy and Clinical ImmunologyMeeting Secretariat, Medivents Ltd, Spirella Building, Bridge Road, Letchworth Garden City, Hertfordshire SG6 4ET

t: +44 (0)1462 630076 e: [email protected]



BSACI 2020 Committee

Programme Planning Committee

Organising Committee

Lucy Common

Dr Matthew Doyle

Rachel Griffin

Dr Natasha Gunawardana

Catherine Hyland

Hannah Kramer

Dr Tom Marrs

Dr Nandinee Patel

Fiona Rayner

Dr Tammy Rothenberg

Dr Nicola Braithwaite

Lucy Common

Dr Chris Corrigan

Dr Matthew Doyle

Dr Shelley Dua

Professor Adam Fox

Rachel Griffin

Dr Natasha Gunawardana

Dr Hannah Hunter

Dr Susan Leech

Dr Tom Marrs

Dr Shuaib Nasser

Fiona Rayner

Dr Tammy Rothenburg

Dr Dermot Ryan

Dr Glenis Scadding

Dr Mohamed Shamji

Dr Isabel Skypala

7bsacimeeting.org

Conference InformationAccessing the Digital PlatformYou will be provided with a link and a password before the event. If you have not received it, please check your junk or spam folder. If you need us to re-send it to you, please email [email protected].

Software RequirementsYou should not need any special software to access the digital event. The digital platform will be fully responsive allowing delegates to watch all sessions from laptop/desktops, iPads/tablets and mobile phones. However, for the optimal experience we recommend you use computers and Google Chrome as the preferred browser.

LanguageEnglish is the official language of the meeting.

Viewing Presentations LiveThe digital event can be accessed on a PC, laptop, or mobile device. Please ensure your sound is switched on. There will be live Q&A during all the sessions, and you will be able to submit questions and comments during the presentations – questions will be put to the speakers and panel during the Q&A period. Please make sure you include the name of the speaker who you want to address when submitting your questions. We have allowed plenty of time for Q&A in order to get through as many questions as possible so please don’t be shy! All questions that are read out will be anonymised if no name is provided.

Viewing Presentations on demand, after the conferenceAll talks will be available to watch on demand from one month after the conference closes. To access the talks, please use the same login as you have been provided for the live event. Of course, the live and interactive elements will not be available but this does at least afford you the opportunity to watch the presentations that you may have missed. In order to be eligible for your CPD points, you must watch the sessions within 4 weeks (so by the end of October).

Exhibition opening timesThe exhibition can be visited at any time during the conference. Some exhibitors have ‘meeting rooms’ open for you to chat to their team, and these will be staffed during the break times as follows:

Thursday 1st October 10:30 – 11:00; 12:30 – 14:00; 15:30 – 16:00

Friday 2nd October 10:30 – 11:00; 12:30 – 13:30

Annual meeting abstractsFollowing the meeting, the abstracts approved by the editor will be published in the Clinical and Experimental Allergy Journal.

Chair and speaker log-inIf you are a speaker or a chair, please ensure that you log in using the specific speaker login that you will be given, at least 30 minutes before the start of the session. You must use your specific login for the session you are



speaking/chairing, and not your general registration login. This is so that we can admit you into the session as a designated speaker with presentation rights, rather than a delegate with viewing only access. Please refer to your speaker brief for full information.

Poster presentations Posters will be displayed in the Poster Area, for the duration of the meeting. Select the poster you wish to view by clicking on its link. You will be able to view the poster and listen to a short presentation by the author. If you are giving an Oral Poster Presentation, you will be provided with a full briefing pack – please refer to this for guidance.

Speaker’s CornerThis year’s ‘Speaker’s Corner’ event is slightly different, and will be an interview with Mr Jon Cruddas, MP, by Professor Adam Fox. We hope you will join us for what promises to be an insightful interview.

Thursday 1st October 10:30 – 11:00

For more information please see the Programme.

Allergy WorkshopsOnce again we have a selection of six interactive workshops as part of this year’s programme.

Practical advice and demonstrations covering topics from skin prick testing to taking a drug allergy history, allergy-specific apps to support your practice and discussions on milk substitutes and asthma triggers.

Thursday 1st October 12:30 – 14:00

For more information please see the Programme.

Accreditation, Evaluation and Certificate of AttendanceThe British Society for Allergy and Clinical Immunology Digital Conference 2020, has been approved by the Royal College of Physicians for 16 CPD credits. As mentioned previously, in order to be eligible for your CPD points, the college rule is that you must view all the presentations within 4 weeks (so by the end of October). Sessions viewed after this time will not be counted. Certificates of attendance will be distributed during the first week of November, once the CPD window closes and we can download your attendance record.

ImmunoCAP™ ISAC assay provides sIgE test results that should be interpreted in the context of clinical history, before making a diagnosis.

For use in clinical laboratories. Phadia AB is the manufacturer and a legal entity of Thermo Fisher Scientific. Availability of EliA and ImmunoCAP tests varies per country. © 2019 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. 102831.AL.GB1.EN.v1.19

Find out more at: thermofisher.com/phadia

Puzzling allergies? Unparalleled answersImmunoCAP ISAC assay:• Clinically relevant

• Clinically validated

• Clinically proven

www.thermofisher.com/phadia


Programme

11bsacimeeting.org

09.00 – 10.30

11.00 – 12.30

10.30 – 11.00

10.30 – 11.00

Interactive Exhibition and Poster Viewing

Speaker’s Corner Session

President’s Plenary Session: Allergy and airway management across the lifecourseChair: Professor Adam Fox, London and Lucy Common, Salford

Welcome Professor Adam Fox, London

Implementing national programmes for improving allergy care Professor Mika Makela, Finland

Overcoming challenges in treating asthmatic and allergic patients Dr Anna Murphy, Leicester

Novel indications for immunotherapy Professor Stephen Durham, London

Chair: Professor Adam Fox, London

Meeting the Challenges of the National Allergy Crisis Mr Jon Cruddas, MP, London

Allergic skin disease Chair: Dr Susannah Baron, London

How safe are topical corticosteroids used in atopic eczema? An overview of systematic reviews Dr Joanne Chalmers, Nottingham

Developmental origins of infantile atopic eczema Dr Sarah El-Heis, Southampton

Novel treatment for urticaria Dr Clive Grattan, London

Optimising respiratory capacity for patients Chair: Professor Graham Roberts, Southampton

RCP NACAP programme national review of asthma admissions Dr James Calvert, Bristol Running a difficult asthma clinic for children Dr Atul Gupta, London Which biologic therapies for allergic airways disease? Dr Runa Ali, London

Day 1 Thursday 1st October 2020

For Speaker information visit: bsacimeeting.org




11.00 – 12.30 Oral abstract presentations Adult Clinical, Allied Health Chairs: Dr Glenis Scadding, London and Rebecca Knibb, Birmingham

O.01 Effectiveness of nurse led new patient allergy clinicAmyn Bhamani

O.02 Compliance with NAP6 recommendations for investigation of general anaesthetic allergy in a nurse led small centre settingKathryn Powrie

O.03 Anaphylaxis in Emergency Department Unit: Before and during COVID-19Leyla Pur Ozyigit

O.04 Dupilumab efficacy in type 2 inflammatory asthma: LIBERTY ASTHMA QUEST studyIan D. Pavord

O.05 Mapping outcomes of supervised open food challenges to a clinical risk stratification model in a specialist UK regional allergy serviceKavitha Sooriyakumar

O.06 Evaluation of a pilot dietetic-led ‘invest-to-save’ rapid access cows’ milk allergy serviceLynn Fitzpatrick

O.07 Preventing peanut allergy in East London - Audit of early peanut introduction amongst high risk infants at The Royal London HospitalRosalynd Estelle Gourgey

O.08 Validation of blinded recipes in children for use in double-blind placebo-controlled food challenges with egg, peanut and milkViktorija Kaminskaite

O.09 Coping strategies of parents of children with food allergy are more adaptive than parents of children with no long-term conditions: a multi-national studyRebecca Knibb

Oral abstract presentations Paediatric Clinical, Primary Care Chairs: Dr Susan Leech, London, and Dr Helen Howells, Southampton

O.10 Covid-19: Allergen-free shopping during a pandemicFarhana Ahad

O.11 Paediatric allergy transition clinics: a service evaluationMorium Akthar

O.12 Food Protein Induced Enterocolitis Syndrome is under recognised by Paediatricians in the UK and Republic of IrelandGary Stiefel

O.13 The rise of telemedicine in a tertiary paediatric allergy service – how often and for which patients?Hazel Collis

O.14 Penicillin-based antibiotic provocation tests – is there scope to switch to single-dose challenge?Boaz Gaventa

O.15 South Asian mothers’ views and experiences of accessing paediatric allergy services in Sheffield for their babies and/or young childrenDr Nicola Jay

O.16 UK Paediatric Allergy Services Survey - ResultsRosy Wells

O.17 A Model of Seamless Allergy CareLouise J Michaelis

O.18 Audit on management of allergic rhinitis in asthmatic children in primary careRachel Lee

Day 1 Thursday 1st October 2020

13bsacimeeting.org


Day 1 Continued

12.30 – 14.00

12.30 – 13.15

13.15 – 14.00

13.00 – 14.00

Lunch Break, Interactive Exhibition, Practical Workshops & Poster Viewing

Practical Workshops

Practical Workshops

Company Symposium for details see page 20

Modified skin prick testing Crystal Johns and Clare Jackson, London

Which milk substitute? Justine Dempsey, London

Intra dermal testing Katherine Knight, London

Asthma triggers Rebecca Batt and Bethan Almeida, London

Taking a drug allergy history Dr Kathleen Sim and Dr Erika Harnik, London

Useful apps Hannah Kramer, London

14.00 – 15.30 Joint BSACI-BSCA session Chair: Dr Deirdre Buckley, BathPatch testing in atopics Dr Graham Johnston, Leicester Clinical cases – an interactive session Dr Jason Williams, SalfordImmediate and delayed allergens affecting the lips and mouth Dr Sarah Wakelin, London

Debates in allergy Chair: Dr Michael Perkin, London Revising the role of adrenaline in anaphylaxis Dr Paul Turner, LondonWhat may milk allergy guidelines recommend in future? Dr David Luyt, LeicesterA national perspective on improving FPIES management Dr Gary Stiefel, Leicester

Respiratory disease Chair: Dr Glenis Scadding, LondonAsthma; another ‘disease of the epithelium’? Professor Clare Lloyd, LondonThe wider implications of pollen allergy Professor Domingo Barber, SpainAllergen management in asthmatic children Dr Clare Murray, Manchester

Difficult conversations Chair: Dr Nicola Brathwaite, LondonAre you telling me there is no food allergy? Deborah Hughes, Crewe The steroid creams do not work anyway… Rachel Griffin, LondonSurely just a little bit at home is ok? Dr Nandinee Patel, London




Day 1 Continued

18.30 – 19.30

15.30 – 16.00

17.30 – 18.30

08.00 – 09.00

Independent Meetings

Interactive Exhibition and Poster Viewing



These will take place at 18:30 on Thursday 1st October and links have been sent to eligible attendees separately via the respective BSACI Professional Groups/Committees.

Nurses Committee Open Meeting-all welcomeAdult Allergy Group MeetingDietitians’ MeetingTrainees’ Meeting

16.00 – 17.30 Celebrating Excellence In Allergy Care And ResearchChair: Professor Adam Fox, London

Jack Pepys Lecture Dr Glenis Scadding, London

Harry Morrow Brown Lecture Dr Michael Perkin, London

Barry Kay AwardsWilliam Frankland Award


08.00 – 09.00

09.00 – 10.30

BSACI AGM

Ethics, allergy and society Chair: Prof. Helen Smith, Singapore

An overview of ethics in allergy Dr Nicola Jay, Sheffield

Skills and challenges in managing Allergy UK phone lines Rebecca McGrath, Allergy UK Shared Decision-Making in Allergy Dr Katherine Anagnostou, Texas, USA

Emerging patterns in food allergy Chair: Dr Nicola Brathwaite, London

Hidden and unusual food allergens Professor Stephen Till, London

New developments in pollen food syndrome Dr Isabel Skypala, London

Changing pressures within the food industry Dr Hazel Gowland, Southampton

Day 2 Friday 2nd October 2020


15bsacimeeting.org

ITN Industry News on allergy and immunology with a BSACI feature on Anaphylaxis

10.30 – 11.00 Interactive Exhibition and Poster Viewing

BSACI Standards of Care Committee (SOCC) joint session Chair: Dr David Luyt, Leicester

Egg allergy; optimising patient care Dr Susan Leech, London

Creating top quality evidence based guidance; lessons from the BTS asthma group Dr Simon Hart, Hull

When can we develop a guideline for food immunotherapy? Dr Marta Vazquez-Ortiz, London

After anaphylaxis Chairs: Sarah Burrell, Singapore and Rebecca Batt, London

Pitfalls in anaphylaxis Dr Glenis Scadding, London

How to minimise teenagers’ risks Dr Bettina Duca, London

How reliable is skin prick testing? Dr Constantinos Kotsapas, London

11.00 – 12.30 Overcoming Inequalities Chairs: Dr Sophie Farooque, London and Dr Nicola Jay, Sheffield

Racism in medicine Dr Zainab Abdurrahman, Canada

The Skin Deep Website Project Dr Michelle Arora, Cambridge

What can we do differently? Dr Habib Naqvi, NHS England

Adverse drug reactions Chair: Dr Chris Rutkowski, London

Hidden intraoperative drug allergens Dr Lene-Heise-Garvey, Denmark

Optimising the recording of adverse drug reactions Dr Louise Savic, Leeds

Solving challenges in suspected paediatric drug reactions Dr Nicola Brathwaite, London

Day 2 Continued

Leading roles for allergy care networks Chair: Professor John Warner, London

Embedding a regional pathway for allergy care in practice Professor John Warner, London

A health economics approach to allergic disease Dr Lavanya Diwakar, Stoke on Trent

A patient perspective on future priorities Lynne Regent, Anaphylaxis Campaign

AHP led services Chairs: Lucy Common, Salford and Deborah Hughes, Crewe

Dietetic – lead clinics for reintroduction and desensitisation of milk in IgE cow’s milk allergy Heidi Ball, Leicester

Getting food introduction right – the occupational therapist’s view Annemarie Sims, London Patient assessment tools and education in the CNS Rhinitis Clinic Janette Bartle, Ipswich

Community dietitian prescribing services Lydia Collins-Hussey, London



Dr Tom Marrs, London

12.30 – 13.30

12.30 – 13.30

15.00


Lunch Break, Interactive Exhibition & Poster Viewing

Close of Meeting

Day 2 Continued

Plenary & Joint CEA session: Year in review Chair: Dr Robert Boyle, London

Year in review: drug allergy Dr Chris Rutkowski, London

Year in review: eczema Dr Susannah Baron, London

A year of changing food allergy practice Dr Michael Perkin, London

13.30 – 15.00


HAE is not...A bee sting, a nut allergy, a side e�ect, latex allergy or IBS1

Hereditary angioedema (HAE)is a rare genetic disorder, causing painful swellings in various parts of the body2-4

● Mouth/Face● Throat● Abdomen● Genitals● Hands/Feet

HAE can have a devastating impact on people’s lives5,6

Because it is rare, HAE is often misdiagnosed7

Children have a50% chanceof inheriting HAE if

one parent has it2

HAE a�ects1 in 10,000to 1 in 50,000individuals worldwide4

But the right knowledge can improve diagnosis and care9

Visit the KnowHAE.co.uk website for accurate information on HAE:

www.knowhae.co.uk

6.2 yearsThe median number of years to get a correct diagnosis3 Almost 47%

UK patients misdiagnosed,even those with a family history1

24% of patientsin a UK survey (12/52)

had unnecessary surgerydue to misdiagnosis8

References1. Zanichelli A, et al. Ann Allergy Asthma 2016;117:394–8.2. Maurer M, et al. Allergy 2018;73(8):1575–96. 3. Longhurst H, et al. Allergy Asthma Clin Immunol 2018;14:284. Banerji A, et al. Allergy Asthma Proc 2015;36(3):213–7.5. Longhurst H, et al. Clin Rev Allerg Immunol 2016;51(2):230–9.

6. Bygum A, et al. Acta Derm Venereol 2015;95(6):706–10.7. Horiuchi T, et al. Allergology International. 2012;61:559-562.8. Patel N, et al. Case Reports in Immunology. Volume 2015, Article ID: 925861, 8 pages.9. Banerji A, et al. Allergy Rhinol 7, 2016;e172-181.

Date of preparation: July 2020 Job code: C-ANPROM/UK//2945

The KnowHae.co.uk website was developed in collaboration with HAE UK


HAE is not...A bee sting, a nut allergy, a side e�ect, latex allergy or IBS1

Hereditary angioedema (HAE)is a rare genetic disorder, causing painful swellings in various parts of the body2-4

● Mouth/Face● Throat● Abdomen● Genitals● Hands/Feet

HAE can have a devastating impact on people’s lives5,6

Because it is rare, HAE is often misdiagnosed7

Children have a50% chanceof inheriting HAE if

one parent has it2

HAE a�ects1 in 10,000to 1 in 50,000individuals worldwide4

But the right knowledge can improve diagnosis and care9

Visit the KnowHAE.co.uk website for accurate information on HAE:

www.knowhae.co.uk

6.2 yearsThe median number of years to get a correct diagnosis3 Almost 47%

UK patients misdiagnosed,even those with a family history1

24% of patientsin a UK survey (12/52)

had unnecessary surgerydue to misdiagnosis8

References1. Zanichelli A, et al. Ann Allergy Asthma 2016;117:394–8.2. Maurer M, et al. Allergy 2018;73(8):1575–96. 3. Longhurst H, et al. Allergy Asthma Clin Immunol 2018;14:284. Banerji A, et al. Allergy Asthma Proc 2015;36(3):213–7.5. Longhurst H, et al. Clin Rev Allerg Immunol 2016;51(2):230–9.

6. Bygum A, et al. Acta Derm Venereol 2015;95(6):706–10.7. Horiuchi T, et al. Allergology International. 2012;61:559-562.8. Patel N, et al. Case Reports in Immunology. Volume 2015, Article ID: 925861, 8 pages.9. Banerji A, et al. Allergy Rhinol 7, 2016;e172-181.

Date of preparation: July 2020 Job code: C-ANPROM/UK//2945

The KnowHae.co.uk website was developed in collaboration with HAE UK

www.knowhae.co.uk

Date of preparation: September 2020 XSU20-C047

TThheerree’’ss nnoo ppllaaccee lliikkee hhoommeeXolair (omalizumab) self-administration in Chronic Spontaneous Urticaria (CSU).

IImmaaggiinnee tthhee bbeenneeffiittss ooff mmoovviinngg XXoollaaiirr oouutt ooff tthhee cclliinniicc -- ffrreeeeddoomm ffoorr yyoouu aanndd yyoouurr ppaattiieennttss::

Xolair is indicated as add-on therapy for the treatment of chronic spontaneous urticaria (CSU) in adult and adolescent (12 years and above) patients with inadequate response to H1-antihistamine treatment1

Clinic capacity increases, giving you more time to see more patients

Gives patients the freedom to fit their treatment around their lives – reduced time spent travelling to and from the clinic meaning less disruption to work or school

With an established long-term efficacy and safety profile and almost 1 million patient years of treatment experience across the brand - Xolair is treatment you

know and trust 1-8

We’ve produced a range of materials to help you discuss self-administration and train suitable patients* on the injection procedure

HHeellppiinngg yyoouurr ppaattiieennttss ffeeeell aatt hhoommee wwiitthh XXoollaaiirr..

*Not all patients are suitable for self-administration.

11.. Xolair® Summary of Product Characteristics. July 2020.

22.. Kulus M et al. Curr Med Res Opin 2010; 26(6): 1285-1293.

33.. Humbert M et al. Allergy 2005; 60: 309-316.

44.. Barnes N et al. J Asthma 2013; 50(5): 529-536.

55.. Tzortzaki E et al. Pulm Pharmacol Ther 2012; 25: 77-82.

66.. Brusselle G et al. Respir Med 2009; 103(11): 1633-1642.

77.. Liehaber M and Dyer Z. J Asthma 2007; 44: 195-196.88.. Novartis data on file. Extrapol tion based on Periodic Safety Update Report (PSUR) 2017.

RReeffeerreenncceess::AAddvveerrssee eevveennttss sshhoouulldd bbee rreeppoorrtteedd..

RReeppoorrttiinngg ffoorrmmss aanndd iinnffoorrmmaattiioonn ccaann bbee ffoouunndd aatt wwwwww..mmhhrraa..ggoovv..uukk//yyeelllloowwccaarrdd.. AAddvveerrssee eevveennttss

sshhoouulldd aallssoo bbee rreeppoorrtteedd ttoo NNoovvaarrttiiss vviiaa uukk..ppaattiieennttssaaffeettyy@@nnoovvaarrttiiss..ccoomm

oorr oonnlliinnee tthhrroouugghh tthhee ppaattiieenntt ssaaffeettyy iinnffoorrmmaattiioonn ((PPSSII)) ttooooll aatt hhttttppss::////ppssii..nnoovvaarrttiiss..ccoomm..

IIff yyoouu hhaavvee aa qquueessttiioonn aabboouutt tthhee pprroodduucctt,, pplleeaassee ccoonnttaacctt MMeeddiiccaall IInnffoorrmmaattiioonn oonn 0011227766 669988337700 oorr bbyy eemmaaiill aatt

mmeeddiinnffoo..uukk@@nnoovvaarrttiiss..ccoomm

Prescribing Information - click here

https://www.health.novartis.co.uk/sites/health.novartis.co.uk/files/2020-03-13_xolair_csu_pi.pdf

19bsacimeeting.org

There are lunchtime and evening industry sponsored satellite symposia during the meeting

Industry sponsored satellite symposia



Thursday 1st October 2020 13.00 – 14.00

AGENDA

Introduction Moderator & Chair: Fabio Ianchetti, Senior Scientific Adviser – Allergy, Immunodiagnostics, Thermo Fisher Scientific

Analysis of the use of ImmunoCAP ISAC in adult patients Dr Jonathan North, Consultant Immunologist, Immunology Department, Sandwell and West Birmingham Hospitals NHS Trust

Analysis of the use of ImmunoCAP ISAC in paediatric patientsDr Susan C. Leech, Consultant / Clinical Lead Paediatric Allergy, Department of Child heath, Kings College Hospital NHS Foundation Trust

Live Q&A

Thursday 1st October 2020 17.30 – 18.30

AGENDA

17.30 Expert Panel Discussion: “Challenges and pragmatic solutions Dr Vincent McGovern (Chair – General Practitioner with Special Interest, Belfast)

Dr Chris Rutkowski (Consultant Allergist and Head of the Department of Allergy at Guy's and St Thomas' Hospital, London)

Alison Donnelly (Acting Clinical Coordinator in Allergy & Immunology at Royal Victoria Infirmary Hospital, Belfast)

18.10 Live Q&A session

18.30 Meeting Close

What allergy patients is ImmunoCAP ISACE112i allergen microarray for? - ‘A retrospective analysis of two clinics’

Challenges and pragmatic solutions in the management of Chronic Spontaneous Urticaria

21bsacimeeting.org

Friday 1st October 2020 12.30 – 13.30

AGENDA

12.30 – 12.50 Role of IL-4, IL-5 and IL-13 in Type 2 Inflammatory Diseases Dr Gursharan Bedi, Consultant Dermatologist

12.50 – 13.10 Clinical perspective on treating Type 2 Inflammation Dr Gursharan Bedi, Consultant Dermatologist

13.10 – 13.30 Live Q&A with Dr Gursharan Bedi

Friday 2nd October 2020 08.00 – 09.00

AGENDA

08.00 – 09.00 Dr Helen Howells reviews the key features of diagnosis and management of food allergy. She also discusses which patients may need adrenaline autoinjectors (AAIs), when and how to prescribe, and an update on the latest availability of AAIs.

Type 2 Inflammatory Diseases: Science and Clinical Practice

Food allergy and anaphylaxis with an update on AAIs



Oral and poster abstracts

23bsacimeeting.org

Oral abstractsAdult Clinical

O.01 Effectiveness of nurse led new patient allergy clinicAmyn Bhamani, Kathryn Powrie, Huw Steven Jenkins

O.02 Compliance with NAP6 recommendations for investigation of general anaesthetic allergy in a nurse led small centre settingAbigail Dunn, Huw Jenkins, Kathryn Powrie

O.03 Anaphylaxis in Emergency Department Unit: Before and during COVID-19Ghayyur Khalil, Taimour Choudhry, Leyla Pur Ozyigit, Mark Williams, Nasreen Khan

O.04 Dupilumab efficacy in type 2 inflammatory asthma: LIBERTY ASTHMA QUEST studyIan D. Pavord, J Mark FitzGerald, Guy Brusselle, Sally E. Wenzel, Klaus F. Rabe, William W. Busse, Alberto Papi, Megan S. Rice, Yamo Deniz, Paul Rowe, Nikhil Amin

O.05 Mapping outcomes of supervised open food challenges to a clinical risk stratification model in a specialist UK regional allergy serviceKavitha Sooriyakumar, Omar Mohamed, Toni Osborne, Sarah Beck, Cathryn Melchior, Jane Heslegrave, Silvy Mathew, Richard Baretto, Anjali Ekbote, Aarnoud Huissoon, Mamidipudi.Thirumala Krishna

Allied Health

O.06 Evaluation of a pilot dietetic-led ‘invest-to-save’ rapid access cows’ milk allergy serviceLynn Fitzpatrick, Karen O'Connor, Kate Maslin

O.07 Preventing peanut allergy in East London - Audit of early peanut introduction amongst high risk infants at The Royal London HospitalRosalynd Estelle Gourgey, Bunmi Raji, Haseena Jearally, Luul Ali, Frances Ling, Antony Aston, Lee Noimark

O.09 Coping strategies of parents of children with food allergy are more adaptive than parents of children with no long-term conditions: a multi-national studyRebecca Knibb, Heather Semper, Cassandra Screti



Paediatric Clinical

O.10 Covid-19: Allergen-free shopping during a pandemicFarhana Ahad, Sarah Wellbelove, Madalina McCairn, Deepan Vyas

O.11 Paediatric allergy transition clinics: a service evaluationMorium Akthar, Pedra Rabiee, Charlene Ng, Philippa Massouh, Shaikha Aljneibi, Nandinee Patel, Haque Rubaiyat, Helen Brough, Kate Swan

O.12 Food Protein Induced Enterocolitis Syndrome is under recognised by Paediatricians in the UK and Republic of IrelandCherry Alviani, Nadeem Afzal, Audrey Dunn-Galvin, George Du Toit, Jonathan Hourihane, Nicola Jay, Louise Michaelis, Mich Erlewyn-Lajeunesse, Gary Stiefel

O.13 The rise of telemedicine in a tertiary paediatric allergy service – how often and for which patients?Hazel Collis, Sibel Sonmez-Ajtai, Elizabeth Hayes

O.14 Penicillin-based antibiotic provocation tests – is there scope to switch to single-dose challenge?Boaz Gaventa, Katherine Knight, Ru-Xin Foong, Nandinee Patel, Marta Krawiec, George DuToit

O.15 South Asian mothers’ views and experiences of accessing paediatric allergy services in Sheffield for their babies and/or young childrenNicola Jay, Sue Peckover, Naheeda Rehman, Farhat Javed, Punita Chowbey

O.16 UK Paediatric Allergy Services Survey - Results Rosy Wells, Cathy McKay, Nick Makwana, Deepan Vyas, Michael Perkin

Primary Care

O.17 A Model of Seamless Allergy CarePaul Netts, Barbara Salas, James Callaghan, James Gardner, Anne McDonnell, Michael McKean, Jane Melvin, Julie Pentland, Hannah Randles, Gillian Vance, Sian Williams, Louise J Michaelis

O.18 Audit on management of allergic rhinitis in asthmatic children in primary careBeth Scott, Rachel Lee, Paul Netts, Gillian Vance

25bsacimeeting.org

Poster Presentations Adult Clinical

P.019 Anaphylaxis with pub food- the role of Alpha-gal AllergySameer Bahal, Samriti Sharma, Bryan Fernandes, F Runa Ali, Ricardo Madrigal

P.020 Long-term Dupilumab treatment up to 100 weeks reduces serum biomarkers in patients with moderate-to-severe atopic dermatitisLisa A. Beck, Diamant Thaçi, Robert Bissonette, Mette Deleuran, Sivan Harel, Robert McDonald, Brad Shumel, Ana B. Rossi

P.021 Case of Haemophagocytic Lymphohistocytosis and presumed COVID-19Swetha Byravan

P.022 Dupilumab efficacy in patients with uncontrolled, moderate-to-severe asthma by immunoglobin E levels at baselineWarner W. Carr, David J. Jackson, Jonathan Corren, Karl-Christian Bergmann, Megan S. Rice, Yamo Deniz, Paul Rowe, Nikhil Amin, Ariel Teper

P.023 Diagnosing primary immunodeficiency disorders in the time of covid-19: in search of warning signs Pamir Cerci, Hakan Akgun, Anil Ucan, Ibrahim Vasi

P.024 Gata-2 Deficiency in a young adultHaggar Elbashir, Pavaladurai Vijayadurai, Ariharan Anantharachagan

P.025 Anaphylactic reaction after drinking tea with honeyHaggar Elbashir, Ariharan Anantharachagan, Pavaladurai Vijayadurai

P.026 Comparison of High versus Low dose oral vitamin D supplementation in improving symptoms score and Quality of Life of Patients with Chronic Spontaneous UrticariaMahmoud El-Sayed, Fawzia AboAli, Dina Sheha, Abeer Eissa

P.027 Lactation anaphylaxis: a case presentationCharlotte Goss, Prathap Pillai

P.028 Stopping immunomodulatory immunoglobulin therapy in an adult patient with atopic dermatitis on dupilumabJohn Guly, Mahreen Ameen, Aoife Tynan, David Lowe

P.029 Improving the documentation of beta-lactam antibiotic allergy in a district general hospitalDaniel Johnson, Katie Heard

P.030 The effect of phototherapy on the inhibition of symptoms associated with allergic rhinitisRoy Kennedy



P.031 Single-centre experience of Omalizumab therapy for chronic spontaneous urticariaSujoy Khan, Sarah Sholtysek, Rebecca Avison, Beverley Fish, Jackie Moor, Pavels Gordins, Steve Holding

P.032 Degmacytes in a patient with resistant urticariaS Khan, N Svenson, R Desborough, S Durairaj

P.033 Long-term safety and effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S studySorena Kiani, Adrian Wu, Jonathan Peter, Avner Reshef, Marcus Maurer, Marcin Stobiecki, Tamar Kinaciyan, Emel Aygören-Pürsün, Jessica Best, Melanie Cornpropst, William P. Sheridan, Henriette Farkas

P.034 Skin testing to Neuromuscular Blocking Agents (NMBAs): Are we changing the non-irritant concentration (NIC) for intradermal test (IDT) to vecuronium and pancuronium?Su Xin Lim, Marina Tsoumani, Susana Marinho, Jia Li Liau

P.035 Efficacy of dupilumab in chronic rhinosinusitis with nasal polyps and comorbid asthma by baseline biomarkers of type 2 inflammation: SINUS-24 and SINUS-52 phase 3 trialsJF. Maspero, C. Bachert, GW. Canonica, BN. Swanson, SH. Cho, S. Harel, A. Jagerschmidt, M. Zhang, X. Mao, LP. Mannent, N. Amin

P.036 The role of Cellular Antigen Stimulation Test in the Diagnosis of Allergy to Food AdditivesAshraf Okba, Fawzia Abo Ali, Mohammed Farres, Asmaa AbdEIRehium, Omneya Zeyada, Dina Sheha

P.037 Audit to assess if regular inhalers are reconciled within 24 hours of admission at Milton Keynes Hospital over a 1-month periodVeeresh Patil, Elodìa Brunetti, Ashna Makwana, Malitha Samarage

P.038 A rare case of perioperative anaphylaxis to heparin during endovascular aneurysm repair with a final diagnosis of multiple drug allergy syndromePatricia Romero, Leyla Pur, Nasreen Khan

P.039 Management of Chronic Spontaneous Urticaria during pregnancy and in woman who plan to conceive while on ongoing treatmentMichael Rudenko, Hilary Longhirst, Lucia Pozo Garcia, Katya Burova, Raisa Meshkova, Roman Kozlov, Alexander Marsland, Emek Kocatürk Göncü

P.040 Prevalence and type of sensitization to pollen allergens in Egyptian patients with respiratory allergy Dina Sheha, Mohammed Sabry, Nabila Mokhtar, Hieba Ezzelregal, Noha Othman, Rasha Shahin

P.041 Millet allergyIason Thomas, Lucinda Kennard

27bsacimeeting.org

Allied Health

P.042 Spare pens in Schools - Are the key recommendations being followed?Alia Boardman, Rosy Wells, Judith Holloway

P.043 Supporting schools to recognize and manage anaphylaxis rapidly: development of a visually friendly resource alongside implementation of a school allergy policyCiaran Cyriac, Deirdre Brown, Neeta Patel

P.044 Do Allergists know about and use Social Media in clinical practice: Results of Social Media Survey at BSACI Annual Congress 2019James Gardner, Claire Honeywell-Alton, Lauri-Ann Van der Poel

P.045 Non-IgE cow’s milk protein allergy is a multiorgan system disorderJoan Gavin, Sally-Ann Denton, Sara Dawson, Rachael State-Davey, Mark Alderton, Mich Erlewyn-Lajeunesse

P.046 Does a maternal elimination diet improve symptoms of non-IgE cow’s milk protein allergy in infants?Joan Gavin, Sally-Ann Denton, Sara Dawson, Rachael State-Davey, Mark Alderton, Mich Erlewyn-Lajeunesse

P.047 Almond challenge outcome audit – would home introduction be safe?Sarah Heath, Susan Leech

Paediatric Clinical

P.048 Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a child with prolonged hospitalisationDr Alaa Ali, Dr Elizabeth Powell, Dr Zaraquiza Zolkipli, Dr Andrew Clark

P.049 Evaluating parental satisfaction with paediatric allergy telephone clinics during the COVID-19 pandemicShirin Beebeejaun, Stacey de Atouguia, Mashal Shamsuddin, Sarumathi Dhanapal

P.050 Parents and primary care perspective on penicillin de-labelling in childrenShravanthi Chigullapalli, Sarah Cartland, Sobia Bilal

P.051 Winter wheals and welts in a toddlerShravanthi Chigullapalli, Sobia Bilal

P.052 Home Food Introduction Service: an initiative for sustaining Paediatric Allergy Services during recovery from Covid-19Rina Chotai, Sue Leech, Nicola Brathwaite, Carly Townsend, Sarah Heath, Telma Ferreira, Tracee Reid



P.054 A case of Neonatal Mastocytosis presenting as congenital urticaria pigmentosa and infected bullaeLucia De Santis, Marian Michael, Sachi Gupta, Lyn Ventilacion

P.055 IPEX (Immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome – a report of heterogeneous phenotype presenting as clinical conundrum in 2 siblingsAyesha Fathani, Samudra Mukherjee

P.056 Allergic profile of children with cystic fibrosis at the Great North Children’s Hospital and a novel perspective on the pathogenesis of Allergic Bronchopulmonary AspergillosisA L Faulkner, M Brodlie, L J Michaelis

P.057 Antibiotic drug desensitisation in the Paediatric Intensive Care UnitSarita Fenton, Alia Boardman, Rosy Wells

P.058 Is home introduction of tuna safe for children with fish allergy?Telma Ferreira, Sue Leech

P.059 Follow up telephone calls may be needed for a successful food challengeMudiyur Gopi, Lucy Tweats, Taylor Jane

P.060 Re-audit of attitudes to precautionary allergen labelling when purchasing products for children with nut allergyIan Gregory, James Gardner, Lee Noimark

P.061 Specific Oral Tolerance Induction to Cow’s Milk: A “Life Changing Experience”Fiona Halton, Niten Makwana

P.062 Drug Allergy In Children: De-labelling the labelFiona Halton, Harriet Swallow, Olivia Horton, Niten Makwana

P.063 The burden of allergy on quality of life and psychological wellbeing in childrenMariyum Hyrapetian, Maria Giovanna Puoti, Dawn Cutler, Emma Brown, Lucy Jackman, Sophia Kallis, Penny Salt, Sarah Eisen, Jonnie Cohen, Leanne Goh

P.064 Signs of early presentation of presumed food allergy in the Neonatal Intensive Care unitMariyum Hyrapetian, Alexandra Fane De Salis, Simone Maechler, Pam Stepney, Ed Gaynor, Angela Huertas, Leanne Goh

P.065 Transplant associated allergy: a comparison of the clinical phenotype and risk factors between paediatric cardiac and renal transplant recipientsF.L. Johnson, J. Flett, H. Lambert, M. Malina, B. Shillitoe, A.R. Gennery, L.J. Michaelis

P.066 Allergic rhinitis in asthmatic children: A comparison of recognition and management of this modifiable risk factor in primary and tertiary careRachel Lee, Beth Scott, Paul Netts, Gillian Vance, Samantha Moss

29bsacimeeting.org

P.067 Update of the BSACI guideline for the management of egg allergySusan Leech, Pamela Ewan, Isabel Skypala, Nicola Brathwaite, Mich Erlewyn-Lajeunesse, Sarah Heath, Heidi Ball, Polly James, Karen Murphy, Maryam Shayeghi, Andrew Clark

P.068 Investigating UK Dermatologists' Knowledge, Confidence, Training and Attitude towards Food Allergy in Atopic DermatitisClaire Lingam, Peter Arkwright

P.069 Oral food challenge to baked milk: Identifying risk factors for clinical reactivity to support decision making about home or hospital-based challengeAnne McDonnell, Bethany Moordcock, Louise Michaelis, Gillian Vance, Michael Greyling, James Gardner

P.071 In-situ multi-disciplinary simulation as a method for informing service development in the immunotherapy clinicElizabeth Powell, Rachel Kirk, Jessica Brown, Hena Salam, Helen Bailie, Rebecca Tibbott, Zaraquiza Zolkipli, Pamela Ewan, Andrew Clark

P.072 Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis (EoE) in a multicentre cohort in LondonMaria Giovanna Puoti, Nandinee Patel, Susanne Dowling, Anthony Aston, Paul Turner, Marco Gasparetto, Sharon Hall, Osvaldo Borrelli, Tom Marrs, Leanne Goh, Jenny Epstein, Edward Gaynor

P.073 Audit of adherence to the South East London Allergic Rhinitis Area Prescribing Committee (SELAPC) Pathway in patients referred to Evelina London Children’s Hospital (ELCH)Suzana Radulovic, Shaikha Al Jneibi, Helen Brough, Susan Chan, Kate Swan

P.074 Pan-London Paediatric Allergy Online Educational Experience during the COVID-19 PandemicAin Satar, Suzanne Dowling, Serena Braccio, Antony Aston, Matko Marlais

P.075 Outcomes of hospital based oral food challengesFarrukh Sheikh, Durga Sigdel, Kelly Tonge, Lyn Ventilacion

P.076 Are we getting diagnosis and prescribing right in cow’s milk protein allergy?Mairi Woodsford, Sarah Mole, Mich Erlewyn-Lajeunesse, Louise Michaelis



Primary Care

P.078 Development and implementation of a nurse-led allergy clinic model in primary care: a feasibility studyMargaret Kelman, Vicky Hammersley, Marilyn Kendall, Mome Mukherjee, Lynn Morrice, Susan Harley, Jurgen Schwarze, Aziz Sheikh

Undergraduate

O.08 Validation of blinded recipes in children for use in double-blind placebo-controlled food challenges with egg, peanut and milkViktorija Kaminskaite, Harriet Mitchell-Riall, Susannah Costelloe, Lorna Pring, Sian Ludman

P.053 Children with Atopic Dermatitis with Allergic Gastrointestinal Origins (ADAGIO) Complex - Th2 allergic inflammatory diseases and use of biological and targeted therapies: Dupilumab and OmalizumabEsther Crompton*, Francis Gainsborough*, James Callaghan, Charlotte Goodhead, Michael McKean, Samantha Moss, Sivakumar Natarajan, Ruth Ord, Benjamin Shillitoe, Jennifer Underhill, Susy Leech, Louise Michaelis*

P.070 Management of anaphylaxis in the paediatric emergency department: a systematic review of the literatureJulia Panascia

P.077 Reviewing first dose reactions at open food challengeSara Zaidi, Morium Akthar, Katherine Knight, Hannah Kramer, Mary Feeney, Kiran Tiwana, Karen Wright, Meenakshi Krishnan, Nandinee Patel, Susan Chan, Alexandra Santos, Kate Swan

P.079 Adrenaline Auto-injector (AAI) carriage in allergy clinics at St George’s HospitalS. Ravichandran

31bsacimeeting.org

Sponsors and exhibitors



Event Sponsors

Exhibitors

33bsacimeeting.org

Event Sponsors

Novartis

www.novartis.com

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 130,000 people of nearly 150 nationalities work at Novartis around the world.

Exhibitor stands can be visited on the digital event platform

Sanofi

www.sanofi.com

Sanofi UK is made up of four Global Business Units (GBUs): Sanofi Genzyme, Sanofi Pasteur, General Medicine and Consumer Healthcare.

With more than 100,000 people across 100 countries, and over 1,200 in the UK, we transform scientific innovation into healthcare solutions to support people across the country, and the globe.

Sanofi Genzyme and Regeneron are committed to providing resources to advance research in immunological diseases in areas of unmet medical needs.



Thermo Fisher

www.thermofisher.com

Thermo Fisher Scientific have been manufacturing specific IgE blood tests for over 40 years with a current portfolio of over 600 complete and molecular allergen tests under our brand ImmunoCAP. ImmunoCAP molecular allergen technology provides additional clinical utility including:

l understanding patient cross-reactions

l patient risk assessment

l an aid to immunotherapy patient selection.

Mylan

www.mylan.co.uk

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine. We offer a growing portfolio of more than 7,500 marketed products around the world.

35bsacimeeting.org

Event Exhibitors

Allergy Therapeutics

www.allergytherapeutics.co.uk/

Allergy Therapeutics are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. Allergies reduce quality of life by preventing individuals and their loved ones from enjoying the everyday activities most take for granted. Through innovative adjuvant technologies we create therapies that act faster and work more efficiently.

Allergy UK

www.allergyuk.org

Allergy UK is the leading UK charity providing support, advice and information for those living with allergic disease. Our mission is to raise the profile of allergy at all levels, with a vision for everyone affected by allergy to receive the best possible care and support. We work with government, professional bodies, Healthcare Professionals and corporates towards our vision and to help improve the lives of the millions of people with allergic disease.

Anaphylaxis Campaign

www.anaphylaxis.org.uk

Anaphylaxis Campaign is the only UK-wide charity solely supporting people at risk from severe allergic reactions. For 25 years we have provided information and support of the highest quality to patients and their families. We work with healthcare professionals, the food industry and pharmaceutical companies to deliver better understanding of allergies and anaphylaxis.



British Society for Allergy and Clinical Immunology (BSACI)

www.bsaci.org

The British Society for Allergy & Clinical Immunology (BSACI) is the national, professional and academic society which represents the specialty of allergy at all levels. Its aim is to improve the management of allergies and related diseases of the immune system in the United Kingdom, through education, training and research.

Clinical & Experimental Allergy Journal

www.bsaci.org/publications/journals

Clinical & Experimental Allergy strikes a balance between clinical and scientific articles publishing reviews, topical editorials, original articles and BSACI Guidelines, written by leading authorities in their field. Published by Wiley on behalf of the BSACI, with an impact factor of 4.741, CEA strives to disseminate the highest quality content in the shortest possible timeframe.

Diagenics

www.diagenics.co.uk

Diagenics are the national distributor for Allergopharma, a major manufacturer and supplier of high-dose hypoallergenic immunotherapy vaccines and standardised skin prick test solutions. Details of these products together with information about the TRUE TEST™ ready-to-use patch testing system for the diagnosis of contact dermatitis will be available at the virtual stand.

37bsacimeeting.org

IQAS Accreditation Programme (RCP)

www.iqas.org.uk

IQAS and QPIDS are accreditation programmes run by the RCP which assess services against a set of standards. Our aim is to promote improvement in allergy and immunodeficiency services across the UK, while accreditation plays an important role in driving change in many areas of healthcare.

Mast Cell Action

www.mastcellaction.org

MAST CELL ACTION is a UK charity for people suffering from Mast Cell Activation Disorders (MCAD), newly recognised disorders arising from the inappropriate release of mast cell mediators, for which there is limited knowledge or treatment. We provide support for patients and their doctors, work to raise awareness of MCAD and fund research.

Natasha Allergy Research Foundation

www.narf.org.uk

The Natasha Allergy Research Foundation has a clear vision; to help and cure people with allergies. It’s main purpose is to fund and support pioneering allergy research bringing the greatest scientific minds together, working for cures & better medicine.



bsaciAnnual Conference

20217th — 9th October

BRIT

ISH S

OCIETY

FOR A

LLERGY & CLINICAL IMMUNO

LOGY

Harrogate Convention Centre

UK

Save the date for the 2021 Conference 7th - 9th October


Annual Digital Conference Programme October 1st - October 2nd … · Oral and poster abstracts 31...

Documents

Transcript of Annual Digital Conference Programme October 1st - October 2nd … · Oral and poster abstracts 31...